Thanks to Jules Levin for providing this paper Comparative Analysis of HIV+ and HIV- Interaction with Testosterone on Bone Mineral Density Reported by Jules Levin ICAAC/IDSA Oct 28 2008 Wash DC R.RAGHUNATHAN 1,2,J.SINACORE 2,K.RYCHLIK 2, J.FARANO 1,C.PACHUCKI 1,2,and N.AZAD 1,2 1 Edward Hines VA Hospital Hines, VA 60141 2 Loyola University Health System,Maywood, IL 60153 […]
LA LIPODISTROFIA Y EL VIH¿DÓNDE ESTAMOS LUEGO DE DIEZ AÑOS?Por Nelson Vergel, Director del Program for Wellness Restoration,powerusa.org La primera vez que apareció un informe acerca de la Lipodistrofia en una Conferencia sobre el VIH fue hace diez años. La excitación y la esperanza de una vida más larga que vino aparejada con la aparición
LA LIPODISTROFIA Y EL VIH Read More »
I am helping Dr Scally publish his book about how to get off anabolic steroids safely. Hopefully this information will help some HIV patients who have been using steroids since they reversed their wasting years ago, and also help people like Cansenco and other athletes. The book should be out in a month or so.
Anabolic Steroid Induced Hypogonadism Read More »
Yes, we’re dummies. You. Me. All 300 million of us. Clueless. We should be ashamed. We’re obsessed about the slogans and rituals of “democracy,” distracted by the campaign, polls, debates, rhetoric, half-truths and outright lies. McCain? Obama? Sorry to pop your bubble folks, but it no longer matters who’s president. See Paul B. Farrell. PAUL
OFF TOPIC; Wall Street’s ‘Disaster Capitalism for Dummies’ Read More »
I have seen some confusion about Tenofovir (Viread, which is in Truvada and Atripla) dosing in those with kidney problems in my pozhealth at yahoogroups.com list, so I am posting this information. So far, most of the problems with tenofovir and kidney function have been reported in treatment experienced patients on boosted protease inhibitors, african
Tenofovir Dosing for patients with kidney dysfunction Read More »
FROM: https://pharmexec.findpharma.com/pharmexec/article/articleDetail.jsp?id=534038 A new study released at the 17th International AIDS Conference in Mexico City on Monday detailed the disconcerting fact that 37.5 percent of US interviewees skip AIDS/HIV treatment due to side effects. AIDS Treatment for Life (ATLIS) polled approximately 3,000 HIV-positive patients from 18 countries to get a better understanding of their treatment
37.5 percent of US patients skip AIDS/HIV treatment due to side effects. Read More »
